Home Industries Market Insights About Us Publisher Contact us

Artificial Intelligence (AI) in Drug Discovery Market Growth, Trends and Forecast to 2028 – Global Analysis By Offering (Hardware, Software, and Services), By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, and Others), By Application (Drug Optimization and Repurposing, Clinical & Preclinical Testing, and Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Research Centers and Academic & Government Institutes) and By Geography

Categories: Life Science   |   Formate :

MARKET DEFINITION 

The process of finding chemical entities with the potential to be medicinal agents is known as drug discovery. The identification of novel molecular entities that may be useful in the treatment of diseases that meet the criteria for unmet medical needs is one of the main objectives of drug development programs. These illnesses are either life-threatening or potentially fatal, and there are no proven effective treatments for them. There are several ways that AI is being used in the drug development process, and they may be divided into categories including target selection and validation, compound screening and lead optimization, preclinical research, and clinical trials.

MARKET DYNAMICS 

The demand for artificial intelligence (AI)-enabled solutions in the drug discovery processes is being driven by the rising demand for the discovery and development of novel pharmacological therapies and the expanding manufacturing capabilities of the life science industry. As the majority of the top-selling products lose their patent protection, manufacturers in the life science sector continually concentrate on restocking their product pipelines. The market is also being driven by an increase in public-private collaborations that support the use of AI-powered solutions in drug discovery and development procedures. However, handling and operating such an advanced system requires expertise in the area. Thus, companies need a workforce with specialized skill sets to create, manage, and implement AI systems as it is a complicated system. On the other hand, emerging countries such as China, India, and South Korea along with some countries from the Middle East. Owing to the significant progress in the pharmaceutical industry, the demand for the technology is expected to rise in the coming years.

REPORT SCOPE 

The report titled “Global Artificial Intelligence (AI) in Drug Discovery Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Artificial Intelligence (AI) in the Drug Discovery market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Artificial Intelligence (AI) in the Drug Discovery market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Artificial Intelligence (AI) in Drug Discovery Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW 

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Artificial Intelligence (AI) in Drug Discovery Market is segmented based on offering, therapeutic area, application, end-user, and region. Based on offering, the market has been segmented into Hardware, Software, and Services, whereas based on therapeutic area, the market comprises Oncology, Neurodegenerative Diseases, Cardiovascular diseases, Metabolic Diseases, Infectious diseases, and Others. Based on application, the market has been segmented into Drug Optimization and Repurposing, Clinical & Preclinical Testing, and Others, whereas, the end-user segmentation includes Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers, and Academic & Government Institutes.

COMPETITION LANDSCAPE 

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by Artificial Intelligence (AI) in Drug Discovery market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Artificial Intelligence (AI) in Drug Discovery market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Artificial Intelligence (AI) in Drug Discovery market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Artificial Intelligence (AI) in Drug Discovery industry in the past three years.

Key players in the Global Artificial Intelligence (AI) in Drug Discovery Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

  • Alphabet Inc.
  • NVIDIA Corporation
  • Microsoft Corporation
  • IBM Corporation
  • Exscientia
  • Schrödinger
  • Atomwise, Inc.
  • BenevolentAI
  • NuMedii
  • Insilico Medicine
  • Deep Genomics
  • GNS Healthcare

COVID-19 IMPACT ANALYSIS ON GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as the broader market, thereby, providing accurate and trustworthy forecasts.

Report Attribute/Metric

Details

Market Size

In USD Million

CAGR

In % (2022-2028)

Base Year

2021

Forecast Period

2022 – 2028

Historical Data

2017 to 2021

Forecast Unit

Value (US$ Mn)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Key Players Analyzed

Alphabet Inc., NVIDIA Corporation, Microsoft Corporation, IBM Corporation, Exscientia, Schrödinger, Atomwise, Inc., BenevolentAI, NuMedii, Insilico Medicine, Deep Genomics, and GNS Healthcare

Customization & Pricing

Available on Request (10% Customization is Free)

 

RESEARCH PROGRAM DESIGN

 

KEY QUESTIONS ANSWERED 

  1. What is the current size of the global Artificial Intelligence (AI) in Drug Discovery market?
  2. What will be the growth rate of the market over the forecast period?
  3. Who are the key manufacturers/vendors of Artificial Intelligence (AI) in Drug Discovery market space?
  4. What are the major market opportunities and market risks faced by the market?
  5. What is the impact of COVID-19 on the market?
  6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
  7. What are the key outcomes of Porter's five forces model?
  8. Who are the distributors, traders, and vendors in the industry?

 

REASONS FOR BUYING THIS REPORT:

  • The report offers comprehensive data on Artificial Intelligence (AI) in the Drug Discovery market elaborating on the current state and future growth prospects both globally and regionally
  • It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
  • The report offers deep-dive insights into each market segment and critical factors responsible for its growth
  • The report presents a precise picture of the dynamic competitive landscape which helps our client advance their market position
  • The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
  • Cross-segment country-level analysis is included in the report which provides granular analysis of more than 20+ countries covered in the report's scope
  • The study includes detailed profiles of major manufacturers to help our readers gain a holistic overview of the market competitors and consequently align their business strategies

Chapter 1.  Executive Summary

1.1.   Market Outlook

1.2.   Market Segment Outlook

1.3.   Geography Outlook

1.4.   Absolute $ Opportunity

Chapter 2.  Research Methodology

2.1.   Research Approach

2.2.   Scope, Definition, and Assumptions

2.3.   Data Sources

2.3.1. Secondary Sources

2.3.1.1.         Preliminary Data Mining

2.3.2. Primary Sources

2.3.2.1.         Statistical Application

2.3.2.2.         Data Triangulation

2.3.2.3.         Research Objective

Chapter 3.  Market Outlook

3.1.   Introduction

3.2.   Key Trends

3.2.1. Offering Trends

3.2.2. Therapeutic Area Trends

3.2.3. Application Trends

3.2.4. End-user Trends

3.3.   Market Dynamics

3.3.1. Market Drivers

3.3.1.1.         Impact Analysis of Market Drivers

3.3.2. Market Restraints

3.3.2.1.         Impact Analysis of Market Restraints

3.3.3. Market Opportunities

3.3.3.1.         Impact Analysis of Market Opportunities

3.3.4. Market Challenges

3.3.4.1.         Impact Analysis of Market Challenges

3.4.   Porter’s Five Forces’ Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of New Entrant

3.4.4. Threat of Substitutes

3.4.5. Competitive Rivalry

3.5.   Value Chain Analysis: Global Artificial Intelligence (AI) in Drug Discovery Market

3.6.   COVID-19 Impact Assessment in Artificial Intelligence (AI) in Drug Discovery Market

3.6.1. Impact Assessment on Global Artificial Intelligence (AI) in Drug Discovery Market

3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4.  Global Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

4.1.   Global Artificial Intelligence (AI) in Drug Discovery Market Share, By Offering, 2017 - 2028 (USD Million)

4.1.1. Hardware

4.1.2. Software

4.1.3. Services

Chapter 5.  Global Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

5.1.   Global Artificial Intelligence (AI) in Drug Discovery Market Share, By Therapeutic Area, 2017 - 2028 (USD Million)

5.1.1. Oncology

5.1.2. Neurodegenerative Diseases

5.1.3. Cardiovascular Disease

5.1.4. Metabolic Diseases

5.1.5. Infectious Disease

5.1.6. Others

Chapter 6.  Global Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

6.1.   Global Artificial Intelligence (AI) in Drug Discovery Market Share, By Application, 2017 - 2028 (USD Million)

6.1.1. Drug Optimization and Repurposing

6.1.2. Clinical & Preclinical Testing

6.1.3. Others

Chapter 7.  Global Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

7.1.   Global Artificial Intelligence (AI) in Drug Discovery Market Share, By End-user, 2017 - 2028 (USD Million)

7.1.1. Pharmaceutical & Biotechnology Companies

7.1.2. Contract Research Organizations

7.1.3. Research Centers

7.1.4. Academic & Government Institutes

Chapter 8.  Global Artificial Intelligence (AI) in Drug Discovery Market Overview, By Geography, 2017 - 2028 (USD Million)

8.1.   Global Artificial Intelligence (AI) in Drug Discovery Market Share, By Geography, 2017 - 2028 (USD Million)

8.1.1. Market Therapeutic Area and Projections, by Countries, 2017 - 2028 (USD Million)

8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 9.  North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

9.1.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

9.1.1.     Market Therapeutic Area and projections, 2017 - 2028 (USD Million)

9.1.2.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

9.1.3.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

9.1.4.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

9.1.5.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.     North America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

9.2.1.     U.S. Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

9.2.1.1.         U.S. Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.1.2.         U.S. Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

9.2.1.3.         U.S. Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.1.4.         U.S. Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.2.     Canada Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

9.2.2.1.         Canada Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.2.2.         Canada Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

9.2.2.3.         Canada Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.2.4.         Canada Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.3.     Mexico Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

9.2.3.1.         Mexico Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.3.2.         Mexico Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

9.2.3.3.         Mexico Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

9.2.3.4.         Mexico Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 10.      Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

10.1.  Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.1.1.   Market Therapeutic Area and projections, 2017 - 2028 (USD Million)

10.1.2.   Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.1.3.   Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.1.4.   Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.1.5.   Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.  Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

10.2.1.   Germany Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.1.1.       Germany Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.1.2.       Germany Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.1.3.       Germany Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.1.4.       Germany Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.2.   France Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.2.1.       France Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.2.2.       France Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.2.3.       France Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.2.4.       France Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.3.   UK Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.3.1.       UK Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.3.2.       UK Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.3.3.       UK Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.3.4.       UK Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.4.   Italy Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.4.1.       Italy Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.4.2.       Italy Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.4.3.       Italy Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.4.4.       Italy Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.5.   Spain Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.5.1.       Spain Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.5.2.       Spain Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.5.3.       Spain Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.5.4.       Spain Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.6.   NORDIC Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.6.1.       NORDIC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.6.2.       NORDIC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.6.3.       NORDIC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.6.4.       NORDIC Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.7.   Russia and CIS Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.7.1.       Russia and CIS Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.7.2.       Russia and CIS Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.7.3.       Russia and CIS Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.7.4.       Russia and CIS Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.8.   Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

10.2.8.1.       Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.8.2.       Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

10.2.8.3.       Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

10.2.8.4.       Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 11.      Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

11.1.  Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.1.1.   Market Therapeutic Area and projections, 2017 - 2028 (USD Million)

11.1.2.   Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.1.3.   Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.1.4.   Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.1.5.   Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.  Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

11.2.1.   India Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.1.1.       India Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.1.2.       India Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.1.3.       India Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.1.4.       India Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.2.   China Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.2.1.       China Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.2.2.       China Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.2.3.       China Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.2.4.       China Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.3.   Japan Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.3.1.       Japan Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.3.2.       Japan Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.3.3.       Japan Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.3.4.       Japan Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.4.   ASEAN Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.4.1.       ASEAN Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.4.2.       ASEAN Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.4.3.       ASEAN Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.4.4.       ASEAN Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.5.   South Korea Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.5.1.       South Korea Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.5.2.       South Korea Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.5.3.       South Korea Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.5.4.       South Korea Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.6.   Australia Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.6.1.       Australia Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.6.2.       Australia Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.6.3.       Australia Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.6.4.       Australia Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.7.   Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

11.2.7.1.       Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.7.2.       Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

11.2.7.3.       Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

11.2.7.4.       Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 12.      South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

12.1.  South America Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

12.1.1.   Market Therapeutic Area and projections, 2017 - 2028 (USD Million)

12.1.2.   South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

12.1.3.   South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

12.1.4.   South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

12.1.5.   South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.  South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

12.2.1.   Brazil Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

12.2.1.1.       Brazil Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.1.2.       Brazil Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

12.2.1.3.       Brazil Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.1.4.       Brazil Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.2.   Argentina Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

12.2.2.1.       Argentina Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.2.2.       Argentina Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

12.2.2.3.       Argentina Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.2.4.       Argentina Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.3.   Rest of South America Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

12.2.3.1.       Rest of South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.3.2.       Rest of South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

12.2.3.3.       Rest of South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

12.2.3.4.       Rest of South America Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 13.      Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

13.1.  Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

13.1.1.   Market Therapeutic Area and projections, 2017 - 2028 (USD Million)

13.1.2.   Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

13.1.3.   Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

13.1.4.   Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

13.1.5.   Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

13.2.  Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Countries, 2017 - 2028 (USD Million)

13.2.1.   GCC Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

13.2.1.1.       GCC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

13.2.1.2.       GCC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

13.2.1.3.       GCC Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

13.2.1.4.       GCC Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

13.2.2.   South Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

13.2.2.1.       South Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

13.2.2.2.       South Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

13.2.2.3.       South Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

13.2.2.4.       South Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

13.2.3.   Rest of Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, 2017 - 2028 (USD Million)

13.2.3.1.       Rest of Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Offering, 2017 - 2028 (USD Million)

13.2.3.2.       Rest of Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

13.2.3.3.       Rest of Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By Application, 2017 - 2028 (USD Million)

13.2.3.4.       Rest of Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 14.      Competitive Landscape

14.1.  Competitive Environment, 2021

14.2.  Strategic Framework

14.2.1.   Partnership/Collaborations/Agreement

14.2.2.   Expansion

14.2.3.   Mergers & Acquisitions

14.2.4.   New Product Development

Chapter 15.      Key Vendor Analysis

15.1.              Alphabet Inc.

15.1.1.       Business Overview

15.1.2.       Product Benchmarking

15.1.3.       Financial Data

15.1.4.       Strategic Overview

15.1.5.       Key Developments

15.1.6.       SWOT Analysis

15.2.              NVIDIA Corporation  

15.2.1.       Business Overview

15.2.2.       Product Benchmarking

15.2.3.       Financial Data

15.2.4.       Strategic Overview

15.2.5.       Key Developments

15.2.6.       SWOT Analysis

15.3.              Microsoft Corporation

15.3.1.       Business Overview

15.3.2.       Product Benchmarking

15.3.3.       Financial Data

15.3.4.       Strategic Overview

15.3.5.       Key Developments

15.3.6.       SWOT Analysis

15.4.              IBM Corporation

15.4.1.       Business Overview

15.4.2.       Product Benchmarking

15.4.3.       Financial Data

15.4.4.       Strategic Overview

15.4.5.       Key Developments

15.4.6.       SWOT Analysis

15.5.              Exscientia

15.5.1.       Business Overview

15.5.2.       Product Benchmarking

15.5.3.       Financial Data

15.5.4.       Strategic Overview

15.5.5.       Key Developments

15.5.6.       SWOT Analysis

15.6.              Schrödinger

15.6.1.       Business Overview

15.6.2.       Product Benchmarking

15.6.3.       Financial Data

15.6.4.       Strategic Overview

15.6.5.       Key Developments

15.6.6.       SWOT Analysis

15.7.              Atomwise, Inc.

15.7.1.       Business Overview

15.7.2.       Product Benchmarking

15.7.3.       Financial Data

15.7.4.       Strategic Overview

15.7.5.       Key Developments

15.7.6.       SWOT Analysis

15.8.              BenevolentAI

15.8.1.       Business Overview

15.8.2.       Product Benchmarking

15.8.3.       Financial Data

15.8.4.       Strategic Overview

15.8.5.       Key Developments

15.8.6.       SWOT Analysis

15.9.              NuMedii

15.9.1.       Business Overview

15.9.2.       Product Benchmarking

15.9.3.       Financial Data

15.9.4.       Strategic Overview

15.9.5.       Key Developments

15.9.6.       SWOT Analysis

15.10.            Insilico Medicine

15.10.1.    Business Overview

15.10.2.    Product Benchmarking

15.10.3.    Financial Data

15.10.4.    Strategic Overview

15.10.5.    Key Developments

15.10.6.    SWOT Analysis

15.11.            Deep Genomics

15.11.1.    Business Overview

15.11.2.    Product Benchmarking

15.11.3.    Financial Data

15.11.4.    Strategic Overview

15.11.5.    Key Developments

15.11.6.    SWOT Analysis

15.12.            GNS Healthcare

15.12.1.    Business Overview

15.12.2.    Product Benchmarking

15.12.3.    Financial Data

15.12.4.    Strategic Overview

15.12.5.    Key Developments

15.12.6.    SWOT Analysis

Chapter 16.   Future Outlook of the Market

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Artificial Intelligence (AI) in Drug Discovery Mar...

RD Code : HP22